All lobbying filings

SMITHBUCKLIN CORPORATION

Lobbying for ASTCT · Healthcare Society

Filing Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Income

$70,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 7

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Medical/Disease Research/Clinical Labs

- Appropriations - CAR-T Therapy clarification - Cures 2.0 Engagement - Cancer Moonshot - NIH Funding

Health Issues

ASTCT Appropriations Billing and Coding CAR-T Therapy Clarifications Cures 2.0 Engagement Revaccination of Immunosuppressed Patients Patient-Care Episode Financial Toxicity NIH Funding Cancer Moonshot Donor Leave Act The Accelerating Kids Access to Care Act Alleviating Barriers to Care Act

Medicare/Medicaid

- CMS coding and billing clarity for CAR-T therapies - CMS engagement on MS-DRG 018 for CAR-T therapies - Patient Care Episode - Financial Toxicity - Cancer Moonshot - The Accelerating Kids Access to Care Act - Alleviating Barriers to Care Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.